ArticleFrontiers in pediatrics2026
Engaging children, adolescents and young adults living with rare diseases as research partners: practical considerations for meaningful involvement.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Engagement of patients has become increasingly recognized as an important principle in medical and health research and development. However, the engagement of young people affected by a rare disease- including children, adolescents, and young adults - has lacked consistent practical guidance that is structured, developmentally appropriate, and ethically grounded. Without clearer practical considerations, researchers may have limited guidance to effectively include this crucial population in ways that respect their evolving autonomy, accommodate diverse contexts, and ensure meaningful impact. This is especially important in rare disease research, where the majority of affected people are children. To address this gap, the International Rare Diseases Research Consortium convened a Working Group on Young People's Engagement, comprising 16 international experts. The group included two young people alongside academic and industry researchers, patient advocates, and clinical specialists with experience working directly with youth. The Working Group reviewed core requirements for engaging young people in research and examined case studies illustrating diverse engagement approaches. Drawing on existing patient engagement frameworks, the group developed expert-informed practical guidance, including a checklist, to support researchers in considering appropriate engagement strategies across developmental stages and research contexts. Strengthening the engagement of young people in rare disease research may help ensure that different types of research, including innovation development, shaping study design, outcome measures and policy decisions, are meaningful, relevant, and reflective of their lived experiences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.